Abstract: This review article aimed to highlight the application and use of artificial intelligence (AI) in optical coherence tomography (OCT) imaging in ophthalmology. Artificial intelligence programs seek to simulate intelligent human behavior in computers. With an abundance of patient data, especially with the advent and growing use of imaging modalities such as OCT, AI programs provide us with the unique opportunity to analyze this plethora of information and assist in making clinical decisions in the field of ophthalmology. Groups around the world have developed and evaluated AI programs that gather data from diagnostic modalities, such as OCT, that assist in the diagnosis and management of ophthalmological diseases with a high accuracy. Artificial intelligence programs using OCT have the potential to play a significant role in the diagnosis and management of ophthalmological disease in the near future. Incorporation of AI in medicine, however, is not without its pitfalls. Some limitations of AI in ophthalmology are also discussed in this review. These include the deskilling of physicians due to increase in reliance on automation, inability of AI programs to take a holistic approach to clinical encounters with patients, requirement of pre-existing strong datasets to train AI programs, and the inability of AI programs to incorporate the ambiguity and variability that is intrinsic to the nature of clinical medicine.
Moreover, ophthalmology is a field that lends itself well to the implementation of AI. With an abundance of patient images, especially with the use of optical coherence tomography (OCT), AI programs provide us with the unique opportunity to analyze this plethora of information and assist in making clinical decisions. For AI to be successfully implemented in any medical field, including ophthalmology, it is important to understand how it works in addition to its potential benefits and limitations. We provide a brief background of AI followed by its implementation using imaging via OCT.
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ARTIFICIAL INTELLIGENCE
Artificial intelligence is a branch of computer science that seeks to simulate intelligent human behavior in computers. It is an umbrella term that encompasses multiple components that include machine learning, deep learning, and Natural Language Processing, which is a method that extracts information from unstructured data (such as clinical notes and medical journals) and turns it into structured data that can then be analyzed via machine learning techniques.
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Machine Learning
Machine learning is "a field of study that gives computers the ability to learn without being explicitly programmed", as described by Arthur Samuel, one of the pioneers of machine learning.
1,2 Machine learning programs are different from basic computer programs in that they can modify the parameters of their algorithms with exposure to more data. 1 Since machine learning programs are designed to adapt in response to the data that are presented to the algorithms, they can make useful predictions based on the parameters of their algorithms. For example, a machine learning program learned the board game Checkers and eventually learned the game well enough to defeat a human champion.
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Deep Learning
Deep learning is a subset of machine learning and a technique that autonomously learns features and tasks from a training dataset. "Deep" refers to the multiple layers of algorithms that the presented data pass through during computation, and a network of interconnected algorithms is called a neural network. 1 Thus, neural networks are sets of algorithms, inspired by the neural connectivity in the human brain, that are designed to recognize patterns in their tasks. Neural networks allow data to pass through layers of algorithms in a multistep process of pattern recognition in order to produce an output, and deep learning refers to the powerful set of techniques for learning via these neural networks.
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Moreover, each step in deep learning allows the program to continually learn and evaluate its progress in order to reach a specific outcome. Unlike machine learning programs, deep learning programs require multiple layers of codes and do not require the programmer to explicitly identify specific features in an image as deep learning programs autonomously learn from training datasets. Therefore, a deep learning program also requires a larger training dataset and higher computational power than that required by a machine learning program.
Artificial neural networks (ANNs) have discrete layers, connections, and directions of data propagation. Thus, the computations performed via deep neural networks can allow it to recognize and distinguish between a simple image, such as a stop light, and a more complex image, such as an abnormal chest radiograph.
1 Moreover, if the program is presented with a plethora of images, both positive and negative training examples, the program can be trained to accurately determine if an image presented matches the positive training examples. Importantly, a subtype of deep learning, known as convolutional neural network, is a deep ANN that is capable of image recognition and classification and has become a pivotal component of deep learning applications in medicine, especially in ophthalmology.
Given the potential of deep neural networks, the study and application of deep learning and AI has increased in recent years and is being explored by many large technology companies and institutions around the world. This review focuses on highlighting the use of these techniques in the diagnosis and management of ophthalmological diseases using OCT.
AI APPLIED TO OCT IMAGING
Groups from around the world have developed and evaluated AI programs that analyze images generated by OCT, an important diagnostic modality used in ophthalmology. In OCT imaging, interference patterns are used to generate a cross-sectional image of tissue with high resolution. This has greatly extended the ability of providers to diagnose pathology in the retina as well as other ocular tissues. As OCT imaging is easily and safely obtained, this technology has generated large volumes of clinical images that make it an excellent target for AI modalities. To date, most published studies in AI and OCT imaging focus on the posterior segment of the eye (retinal diseases and glaucoma), but recent studies have started to investigate its use in the anterior segment. These studies are summarized in Table 1. 3-40 High levels of accuracy have been reported in interpreting various disease processes in the eyes. With the rapid advances of AI in OCT interpretation, AI strategies may soon dramatically improve ophthalmic diagnostics.
Macular Edema
Macular edema is a sight-threatening pathology characterized by fluid accumulating in the macula, a posterior section of retina that services central vision. It may result from a variety of etiologies that involve inflammatory, vasculopathic, or degenerative processes. Vision-impairing edema is often difficult to identify with a traditional fundus examination but is easily detectable on OCT imaging, which can identify retinal thickening or pockets of fluid that characterize the condition. Automating the analysis of macular OCT images could help screen patients at risk of macular edema, such as those with diabetes. Several groups have developed AI programs in order to detect macular edema using OCT. An earlier study by Liu et al 3 reported on the performance of an AI program to diagnose several retinal diseases including macular edema and age-related macular degeneration (AMD). They used machine learning techniques to develop an automated method to determine macular pathology -macular hole, macular edema, and AMD -from fovea-centered cross sections in 3-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) images. 3 To determine the program's accuracy, they examined how often its diagnosis concurred with a majority opinion from 3 ophthalmologists, who labeled each fovea-centered slice independently. Their program was found to be highly accurate, achieving an area under the receiver operating characteristic curve (AUC) of more than 0.94 for all 3 macular pathologies. 3 In another study, Liu et al 41 also used machine learning approaches, specifically support vector machine (SVM) classifiers, to identify the presence of normal macula, along with several macular pathologies, via analysis of OCT images, and their results based on 326 OCT scans demonstrated an AUC of more than 0.93.
One of the most common causes of macular edema is diabetic macular edema (DME), a major cause of vision loss in diabetic patients. Diabetic macular edema has been the focus of several studies analyzing how OCT can be applied to macular edema, and it was the target of a study by Chan et al 4 to combine several deep learning architectures to distinguish OCT images between normal and DME subjects. Specifically, they combined deep learning features of AlexNet, VggNet, and GoogleNet and validated their program using 2 datasets (from the Singapore Eye Research Institute and the Chinese University of Hong Kong), and their program had an accuracy of 93.75%. 4 Alsaih et al 5 used a dataset from the Singapore Eye Research Institute containing 32 OCT image volumes (16 DME cases and 16 normal controls) and compared various machine learning techniques in order to find one that best identified DME with a sensitivity of 87.5% and specificity of 87.5%. Gerendas et al 6 performed a pilot study that also highlighted the potential of machine learning programs for detecting and analyzing the prognosis of patients with DME. Their results showed 312 potentially predictive features for proper prognosis for best-corrected visual acuity, with the most important one being intraretinal cystic fluid in the outer nuclear layer in the 3-mm area around the fovea. 6 Another group, Alsaih et al 42 used SD-OCT volumes for detecting DME with a sensitivity of 75% and specificity of 87% on a challenging dataset.
Diabetes is the main cause of macular edema, and hence determining its etiology is important for treatment. These etiologies can often be determined with the help of OCT images, and several AI programs have been shown to help identify when edema may have resulted from diabetes, compared with another etiology. The program developed and evaluated by Hecht et al 7 is a machine learning program that used parameters from OCT images -including existence of hard exudates, subretinal fluid, pattern of macular edema, and location of cysts within the retinal layers -to distinguish DME from pseudophakic cystoid macular edema. This distinction is important for treatment modality. Their program achieved a sensitivity of 94% to 98%, a specificity of 94% to 95%, and an AUC of 0.937 to 0.987, depending on the specific method, for confirming a diabetic etiology for edema.
Rodrigues et al
8 could identify diabetic retinas from OCT by segmenting the retinal vascular network. This technique could distinguish diabetic from healthy retinas with an accuracy of 98%, a specificity of 99%, and a sensitivity of 83%. Similar results emerged when they applied the same technique to classify the optic nerve head region. 8 High accuracy in identifying macular edema has been reported with other AI programs using various strategies. Jemshi et al 9 developed an algorithm that detects macular edema using segmentation of the inner limiting membrane and the choroidal layer that is based on graph theory and dynamic programming, and their program achieved a high accuracy Support vector machine classifier for detection of DME Alsaih et al, 2017 5 Machine learning to detect DME Gerendas et al, 2017 6 Machine learning strategy for predicting prognosis in DME from OCT findings Montuoro et al, 2017 13 Unique machine learning strategy for detecting macular edema Murugeswari and Sukanesh, 2017 10 Comparison of machine learning algorithm for the detection of macular edema Roy et al, 2017 12 Deep learning for detecting macular edema Chan et al, 2018 4 Deep learning strategy for identifying DME Hecht et al, 2018 7 Machine learning program to distinguish DME from pseudophakic cystoid macular edema from OCT findings Jemshi et al, 2018 (99.5%), sensitivity (100%), and specificity (99% 14 Sun et al 15 also developed an automated classification program, based on machine learning approaches, for detecting the presence of DME and AMD, another cause of subretinal fluid accumulation. Its ability to correctly identify these 2 pathologies was evaluated using the Duke spectraldomain dataset and a large OCT dataset from Beijing, with each set having both DME and AMD patients along with normal eyes. The program correctly distinguished between normal, AMD, and DME eyes with an average accuracy of 97.8% in the Duke dataset and 99.8% in the Beijing dataset. 15 These studies revealed that current AI programs can maintain high accuracy even when considering multiple pathologies.
Age-Related Macular Degeneration
Age-related macular degeneration is one of the most common causes of irreversible vision loss in the developed world. Its pathogenesis is not fully understood but involves degenerative changes in the outer retina. These retinal structures can be imaged with OCT, which is used to identify patients with the condition and grade the severity. Identifying severity is important as AMD can lead to choroidal neovascularization (CNV), a sight-threatening complication that requires urgent treatment. With the key role of OCT imaging in AMD, extending its application through the use of AI could facilitate its detection and management.
Over the past few years, multiple groups have reported AI strategies for detecting AMD. Treder et al 16 developed and evaluated a deep learning program, using the TensorFlow framework developed by Google, for detection of AMD using SD-OCT. They used 100 untrained cross-sectional OCT images (50 with AMD and 50 healthy controls) to evaluate their program, and the results demonstrated an accuracy of 0.997 in the AMD group and 0.9203 in the healthy group with high significance (P < 0.001). 16 Similarly, Kugelman et al 17 developed a recurrent neural network, as opposed to the traditionally used convolutional neural network, to segment retinal layer boundaries in OCT images from healthy children and also from patients with AMD. Their results demonstrate that recurrent neural networks are a viable alternative to convolutional neural networks with high accuracy and consistency. 17 Given that OCT and retinal fundus images are the main imaging modalities used to diagnose AMD, both were used by a deep learning program developed by Yoo et al 43 for automatic detection of AMD. Their results showed an AUC of 0.906 and an accuracy of 82.6% with OCT alone, AUC of 0.914 and accuracy of 83.5% with fundus image alone, and the best AUC of 0.969 and accuracy of 90.5% with combined OCT and fundus images. 43 Another study, performed by Seebock et al, 18 developed a machine learning program that used unsupervised identification of anomalies as markers on retinal OCT scans for identification of AMD, and their results showed an accuracy of 81.40% and an AUC (using a publicly available dataset) of 0.944, displaying the value to unsupervised machine learning program in diagnosing AMD using OCT images. Similarly, Venhuizen et al 19 evaluated a machine learning algorithm for automatic detection and classification of AMD using OCT images, and their results (similar performance to human graders) showed an AUC of 0.980, a sensitivity of 98.2%, and a specificity of 91.2%.
The progression of AMD is highly variable and can be complicated by the development of CNV, a sight-threatening complication that warrants urgent treatment. Schmidt-Erfurth et al 20 proposed an AI program that individually predicts the progression of AMD to CNV or the dry type with geographic atrophy (GA) using OCT. Their program was evaluated using images from 459 eyes (159 of which progressed to advanced AMD with 114 eyes displaying CNV and 45 displaying GA), and their program was able to differentiate converting versus nonconverting eyes with a performance (AUC) of 0.68 (CNV) and 0.80 (GA).
20 Also studying progression, Bogunovic et al 21 developed a machine learning method for automated image analysis to identify and characterize individual drusen at baseline and follow their development over time via OCT images. Their results showed an AUC of 0.75, demonstrating the ability of AI and OCT to predict outcomes for patients with AMD.
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Another challenge in AMD management is predicting its impact on vision in the presence of other pathologies such as cataract. Estimating the visual impact of the AMD could guide management decisions, such as whether cataract extraction is worthwhile. To this and similar goals, several groups have developed AI algorithms that estimate visual acuity in AMD patients based on their OCT findings. Aslam et al 22 estimated visual acuity from OCT images of patients with AMD using a neural network. Using 1210 OCT scans, they validated a machine learning program, with a 10-layer feed-forward neural network and 1 hidden layer of 10 neurons, and demonstrated a root mean square error of 8.2 letters for predicted compared with actual visual acuity and a mean regression coefficient of 0.85. 22 They also demonstrated that, when the external limiting membrane is intact, there is a slower decline in acuity with increasing subretinal fluid but a faster decline with increasing subretinal hyperreflective material. On the other hand, when the external limiting membrane was not intact, all visual acuities were reduced.
Retinal Disease Management
The reach of AI in OCT analysis is rapidly advancing and it is now being applied to many other retinal pathologies. 44, 45 Examples include vitreomacular adhesion during anti-vascular endothelial growth factor (anti-VEGF) therapy, retinal nerve fiber loss in multiple sclerosis, and photoreceptor changes in choroideremia and retinitis pigmentosa. 46 Additionally, it is being used to automatically generate segmentation layers of the retina and choroid, with the potential to further advance the use of OCT in various disease processes. 47, 48 With the increased robustness and applicability of AI in this field, it is hoped that these algorithms can positively impact the diagnosis and management of various diseases soon.
An exciting example of how AI can be used to guide management was reported by De Fauw et al, 23 who demonstrated that an OCT-analyzing AI program could match or exceed experts in making referral recommendations. The AI strategy used in this case was a deep learning architecture trained to generate 3D tissue segmentations. After training on 14,884 OCT scans, it was then tested on its ability to identify urgent ophthalmic conditions from OCT scans alone. It was deemed correct if its recommendation, such as immediate or routine follow-up, matched the patient's actual clinical course, which was known from the patient's clinical records. The program was found to match or exceed retina specialists who had access to the same OCT scan along with other clinical data such as patient's age and clinical history. Excitingly, the architecture was easily retrained to interpret images generated by other OCT devices on a much smaller second training set. The finding shows that this approach, a novel architecture that generates 3D tissue segmentation, can lead to OCT interpretation that is independent of device or at least can avoid the need for multiple large training sets. 23 This robustness along with its accuracy in referrals show that current AI techniques could likely impact how patients are screened, helping to triage patients more efficiently than human providers alone. 23 Artificial intelligence programs that guide screening and management based on OCT images have also been explored by other groups. Kermany et al 24 developed a clinical decision support algorithm, using deep learning, that provided a diagnostic framework and screening for patients with blinding retinal diseases, including AMD and DME. Prahs et al 25, 49 have developed an AI program that evaluated the need for anti-VEGF treatment, a commonly used class of medications for treating macular edema and proliferative vasculopathies. Their program, a convolutional ANN, attempts to predict the indication for using anti-VEGF treatments based on central retinal OCT scans without human intervention. 25 Their results demonstrated a prediction accuracy of 95.5% and suggested the potential usefulness of this program as a clinical support system for physician even though they still recommend a final evaluation by the treating physician. 25 Even if ceding final decisions to a human provider, it is very feasible that similar programs may soon be used to help screen or monitor patients.
Glaucoma
Glaucoma is a potentially blinding condition in which a patient suffers progressive loss of the retinal nerve fiber layer (RNFL) and related nervous structures. This process is often asymptomatic until late in the disease course, hence early diagnosis and treatment can often halt progression and prevent irreversible vision loss. Detection and monitoring are therefore critical, and OCT imaging has revealed itself as an excellent addition to other tests. Here the structures of interest are the RNFL and the ganglion cell layer (GCL), which are both progressively thinned in glaucoma. Thinning of these structures can be directly analyzed along with corresponding changes to the optic nerve head.
Classification of RNFL thickness using AI programs and OCT has been an important way for predicting glaucoma diagnosis and progression. 25, 27, 50, 51 Bizios et al 26 compared 2 machine learning classifiers -ANNs and SVMs -to diagnose glaucoma, and their results showed that both performed well, with an AUC of 0.982 for ANNs and 0.989 for SVMs. Similarly, Grewal et al 27 developed and trained an ANN, using OCT images, to differentiate healthy eyes from eyes with primary open angle glaucoma (POAG) and POAG suspects, and their program had an overall classification rate of 65%, specificity of 60%, and sensitivity of 71.4%. Their program, however, tended to label POAG suspects as POAG.
Several studies have utilized AI to develop programs to automatically diagnose glaucomatous neuropathy based on OCT images. [28] [29] [30] Burgansky-Eliash et al, 28 one of the first groups in the field of glaucoma to use AI and OCT, developed a machine learning program that detects glaucomatous abnormalities from OCT findings, and their results demonstrated an AUC of 0.981, a sensitivity of 97.9%, and a specificity of 92.5%. Similarly, Huang and Chen, 29 another pioneer in the field, developed an AI program, using different classifiers that differentiate between healthy and glaucomatous eyes. Muhammad et al 31 developed a hybrid deep learning program that used GCL and RNFL data from OCT to classify glaucoma suspects. In 102 eyes of 102 patients, the program identified glaucoma suspects with 93.1% accuracy, demonstrating the ability of the deep learning program to distinguish healthy eyes from early glaucomatous eyes with OCT data alone. 31 Glaucomatous changes to the optic nerve head have long been used by clinicians to identify at-risk patients, and optic nerve head changes are also a target of multiple AI strategies in OCT. One example is a program developed by Devalla et al 32 that digitally stains OCT images of the optic nerve head, identifying the neural and connective tissues. This digital staining allows automated measurements of optic nerve parameters that are affected by glaucoma. Their program was able to stain 6 tissue layers (RNFL, retinal pigment epithelium, all other retinal layers, choroid, peripapillary sclera, and the lamina cribrosa) for 40 healthy and 60 glaucomatous eyes, and their results showed a dice coefficient of 0.84, a sensitivity of 92%, a specificity of 99%, and an accuracy of 94%. 32 Another optic nerve head parameter, Bruch membrane opening-minimum rim width (BMO-MRW), is a quantitative parameter that can be determined from OCT images. 33 This parameter is thought to estimate the nerve fiber bundles at the optic nerve head and might be useful to monitor the neuroretinal rim in glaucoma. 33 An important precursor to this measurement is determining the boundary of the Bruch membrane opening (BMO). This can be done by manually deleting the boundary, but now can also be done using machine learning. Miri et al 33 presented a program that used a machine-learning graph-based approach to identify the BMO with high accuracy. A potential application for the BMO-MRW has been recently reported by Thompson et al. 34 They presented a deep learning program that could use BMO-MRW to predict glaucoma with an AUC of 0.933. Excitingly, they also showed that their deep learning program could use the BMO-MRW as a reference for training to analyze the optic discs on fundus photos. After analyzing 7426 fundus photos with the BMO-MRW as a comparison, their deep learning program could predict glaucoma from fundus photos with an AUC of 0.945. 34 Given that glaucoma causes changes in multiple optic nerve and retinal structures, future strategies are likely to incorporate multiple measurements to best estimate glaucoma risk. For example, macular vessel density was found to be a useful measurement that could add predictive value when combined with other glaucoma-related measurements. In a report by Park et al, 35 the macular vessel density and GCL thickness were analyzed by an ANN. Their results demonstrated an enhanced performance (AUC of 0.87) in diagnosing glaucoma when using macular vessel density in addition to GCL thickness. 35 Numerous other multimodal approaches have been reported. Miri et al 36 demonstrated the benefit of using a multimodal segmentation of optic disc and cup from OCT and color fundus photography, via machine learning program, to classify the optic disk and cup boundaries, and their results demonstrated that multimodal approaches outperform unimodal approaches (OCT only) in segmenting the optic cup and disc. Other multimodal strategies have combined OCT and standard automated perimetry. A study used a machine learning algorithm to differentiate between healthy and glaucomatous eyes, and the results showed an AUC of 0.805 and 0.931 (for the 2 classifiers). 30 Glaucoma has numerous subtypes and several studies have sought to classify the type of glaucoma using AI and OCT images. A primary distinction is whether glaucoma is open-angle, meaning that the trabecular meshwork is open to the anterior chamber, or closed-angle, in which the trabecular meshwork is closed. This determination can be challenging, and anterior segment OCT (AS-OCT) is a promising method for an objective and standardized means of grading angle structures. Xu et al 37 reported a machine learning program that could grade angles as open or closed with high accuracy and efficiency. Specifically, this is a multistep process that converts an AS-OCT into a binary (black and white) image, and then uses several additional processing steps to identify the angle. Using this algorithm their program achieved an AUC of 0.921, an accuracy of 84% and a specificity of 85%, which they report it outperformed the clinical feature-based methods. 37 In another study, Niwas et al 38 developed a machine learning algorithm that uses AS-OCT images for determining the mechanism involving angle-closure glaucoma diagnosis. Interestingly, their machine learning program could distinguish between 5 classes of angle-closure glaucoma mechanisms -iris roll, lens, pupil block, plateau iris, and no mechanism -based on the OCT. 38 
Corneal Diseases
The multiple layers of the human cornea can be examined by OCT, generating cross-sectional images that can help identify pathologies or surgical complications. Treder et al 39 evaluated a deep learning program that used AS-OCT to automatically detect graft detachment after Descemet membrane endothelial keratoplasty. Using data of 111 eyes of 91 patients, 1172 AS-OCT images (of 609 attached and 563 detached grafts) were used to train and test the program, and their results showed a sensitivity of 98%, a specificity of 94%, and an accuracy of 96%. 39 Another group, Yousefi et al 40 developed an unsupervised machine learning program that used OCT images from 12,242 eyes to identify and monitor stages of keratoconus. Their AI program classified the images into 4 main categories using Ectasia Status Index -a cluster of mainly healthy eyes, a cluster of mostly healthy eye and eyes with forme fruste keratoconus, a cluster of mostly healthy eyes with mild keratoconus, and a cluster of eyes with mainly advanced keratoconus. Their results suggest that AI can be applied to identifying the status and severity of eyes with keratoconus.
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LIMITATIONS OF AI
Although AI is likely to play an increasing role in healthcare and has the potential to greatly enhance patient care, there are several limitations and challenges that come along with the incorporation of AI in medicine.
1 First, the increased reliance on automation and technology might lead to a phenomenon described as deskilling in physicians that negatively affects the ability of future physicians to make informed decisions and form opinions based on detectable signs and symptoms. Second, AI programs are often unable to take a holistic approach to clinical scenarios and cannot fully consider the social and psychological aspects of a clinical encounter that are often taken into consideration by a skilled clinician. Third, AI requires a strong training dataset as a reference standard in order to produce accurate outcomes. Even though an AI program can produce consistently accurate results through the use of a good training dataset, its performance using real-world images might not be accurate. For example, Roach 52 performed an experiment in which they changed a few pixels in fundus photos with diabetic retinopathy. These changes were undetectable to an ophthalmologist's eye, who still correctly identified the images as having diabetic retinopathy, but the AI program altered the outcomes, more than half of the time, and inaccurately marked these images as normal. 52 Additionally, as reported by Ting et al, 2 although many AI programs perform well during testing, more groups should demonstrate power calculations for evaluating the performance of their AI programs using independent datasets. Lastly, AI programs are often unable to incorporate the ambiguity and variability that is intrinsic to the observation and decision making in clinical medicine. This is especially true for diseases like glaucoma and retinopathy of prematurity because of the inherent disagreement and interobserver variability that exists among clinicians in the classification of the diseases. Although AI programs can analyze and learn from data at a level that is not possible by any single physician, the process by which deep learning algorithms learn to produce an output is not fully understood and introduces a level of uncertainty in clinical decision making. Therefore, it is imperative that we seek to better understand the technology that we will likely use to treat our patients in the near future.
1
CONCLUSION
of imaging modalities -such as OCT -AI is likely to play a major role in healthcare, especially in ophthalmology, in the near future.
1 Artificial intelligence programs seek to simulate intelligent human behavior in computers, and studies around the world have demonstrated the ability of different types of AI using OCT to aid in the diagnosis and management of ophthalmological diseases with high accuracy. 1 As highlighted in our review, a large number of AI programs using OCT have been developed, and, given the outpatient nature of practice and the increased use of OCT imaging, ophthalmology will lend itself well to the implementation of AI for improving patient care.
